2024 annual financial data
SpyGlass Pharma 2024 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -27,064,000 USD and net income was -29,164,000 USD.
Operating cash flow was -22,027,000 USD.
Get free SpyGlass Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -27,064,000 USD
- Net income
- -29,164,000 USD
- Operating cash flow
- -22,027,000 USD